80466-80-4

Usage

Synthesis Reference(s)

Journal of Heterocyclic Chemistry, 18, p. 997, 1981 DOI: 10.1002/jhet.5570180530

InChI:InChI=1/C5H6ClNO2S2/c1-3-5(11(6,8)9)10-4(2)7-3/h1-2H3

Upstream product

• 541-58-2 2,4-dimethylthiazole 
• 114389-50-3 2,4-dimethylthiazole-5-sulfonic acid 

Downstream Products

• 80466-90-6 dimethyl-1,3-thiazole-5-sulfonamide 
• 80466-93-9 2,4-Dimethyl-thiazole-5-sulfonic acid phenylamide 
• 80467-26-1 C₁₂H₁₃N₃O₃S₂ 
• 80467-07-8 C₁₂H₁₂ClN₃O₂S₂ 
• 80467-08-9 C₁₂H₁₁Cl₂N₃O₂S₂ 
• 164154-91-0 N-(4-methoxyphenyl)-N,2,4-trimethylthiazole-5-sulfonamide 
• 915408-10-5 C₃₇H₃₁FN₄O₄S₂ 
• 881677-43-6 1-[(2,4-dimethyl-1,3-thiazol-5-yl)sulfonyl]-4-methyl-5-phenyl-1H-pyrrole-3-carbaldehyde 
• 1269500-27-7 C₂₀H₂₈N₄O₅S₂ 
• 1416637-13-2 C₂₈H₃₄N₄O₃S₂ 
• 1380228-97-6 N-(2,4-difluoro-3-(3-(9-(tetrahydro-2H-pyran-2-yl)-9H-purin-6-yl)pyridin-2-ylamino)phenyl)-2,4-dimethylthiazole-5-sulfonamide 
• 1452395-01-5 C₁₈H₂₃N₃O₄S₂ 
• 1452394-56-7 C₁₇H₂₀N₄O₂S₂ 
• 1452394-41-0 C₁₈H₂₃N₃O₃S₂ 

Relevant academic research and scientific papers

Quinazolinone Compound and Application Thereof

The present invention relates to a series of quinazolinone compounds and applications thereof as PI3Kα inhibitors. In particular, the present invention relates to a compound shown in formula (I) and a tautomer or pharmaceutically acceptable salt thereof.

PYRAZOLE DERIVATIVES AND THEIR USE AS PI3K INHIBITORS

The invention concerns pyrazole derivatives of Formula( I) or pharmaceutically-acceptable salts thereof, wherein each of R, Ring A, m, R1, R2 and R3 has any of the meanings defined hereinbefore in the description; processe

INDOLE DERIVATIVES

The invention concerns indole derivatives of Formula (I) or pharmaceutically-acceptable salts thereof, wherein each of Ring A, m, R1, R2, n, R3 and G1 has any of the meanings defined hereinbefore in the description; processes for their preparation, pharmaceutical compositions containing them and their use in therapy, for example in the treatment of disease mediated by a PI3K enzyme and/or a mTOR kinase.

Bispiperidines as antithrombotic agents

Novel compounds which are inhibitors of the binding of fibrinogen to the Gp IIb/IIIa platelet receptors, and which can be used therepeutically as antithrombotic agents

Some Heterocyclic Sulfonyl Chlorides and Derivatives

The syntheses of 4- and 5-chlorosulfonylfuran-2-carboxylic acid (Ia,IIa), 4-chlorosulfonylfuran-2-carboxamide (Ib), 3,5-dimethylpyrazole and isoxazole-4-sulfonyl chlorides (IIa, IVa) and 2,4-dimethylthiazole-5-sulfonyl chloride (Va) are described.The sulf